Report #2827332

Received Feb 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: CO
Recovered: Unknown
Vaccinated: Jan 22, 2025
Onset: Jan 22, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	UNK	941579	IM / LA

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

Received a Dose of HEPLISAV-B Today, Which Expired on 04-Jan-2025; Initial report received on 22-Jan-2025. A nurse reported that a 39-year-old male received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization that had expired. No medical history or concomitant medications were reported. On 22-Jan-2025, the patient received a dose of a hepatitis B vaccine HEPLISAV-B (lot number 941579, expiration date 04-Jan-2025; NDC number not available) intramuscularly in the left deltoid. The dose of HEPLISAV-B administered had expired on 04-Jan-2025. No side effects were reported. No other information was available. Company Comment: The company assessed the event as non-serious; Sender's Comments: The company assessed the event as non-serious